TWA
GNCA

TCI Wealth Advisors’s Genocea Biosciences, Inc. GNCA Stock Holding History

TCI Wealth Advisors’s Portfolio GNCA Stock Details GNCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-100
Closed – – 1747
2020
Q3 		$0 Buy
+100
New +$262 ﹤0.01% 1733
2019
Q4 		– Sell
-200
Closed -$1K – 1767
2019
Q3 		$1K Hold
200
– – ﹤0.01% 1471
2019
Q2 		$1K Buy
+200
New +$1.04K ﹤0.01% 1389

Other funds holding GNCA

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

TCI Wealth Advisors's GNCA Position: Q4 2020 in Review

TCI Wealth Advisors sold out of Genocea Biosciences, Inc. (GNCA) in Q4 2020, closing a stake of 100 shares.

TCI Wealth Advisors first reported a position in GNCA in Q2 2019 and held it in 3 quarters. The position peaked at $1K in Q3 2019. 39 funds tracked by Wall St. Rank hold GNCA as of Q4 2020.

  • TCI Wealth Advisors reported no remaining Genocea Biosciences, Inc. position as of Q4 2020 after selling out during the quarter.
  • TCI Wealth Advisors sold 100 Genocea Biosciences, Inc. shares in Q4 2020.
  • TCI Wealth Advisors first reported a position in Genocea Biosciences, Inc. in Q2 2019 and held it in 3 quarters.
  • TCI Wealth Advisors's Genocea Biosciences, Inc. position peaked at $1K in Q3 2019.
  • 39 funds tracked by Wall St. Rank held Genocea Biosciences, Inc. as of Q4 2020.

Based on TCI Wealth Advisors's 13F filing for Q4 2020, filed 21 Jan 2021.